REQUEST A DEMO
Total
USD $0.00
Search more companies

Industria Farmaceutica Investpharma S.A.S. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Pharmaceutical and Medicine Manufacturing | Pharmacies and Drug Stores
Full name: Industria Farmaceutica Investpharma S.A.S. Profile Updated: May 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Industria Farmaceutica Investpharma S.A.S. is a company in Ecuador, with a head office in Samborondon. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was established on December 08, 2021. It currently has a total number of 1 (2023) employees. Its’ total assets recorded a growth of 19787.76%.

Headquarters
Samborondon
Samborondon; Guayas;

Contact Details: Purchase the Industria Farmaceutica Investpharma S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Industria Farmaceutica Investpharma S.A.S. report to view the information.
Outstanding Shares:
Purchase the Industria Farmaceutica Investpharma S.A.S. report to view the information.
Registered Capital:
Purchase the Industria Farmaceutica Investpharma S.A.S. report to view the information.
Incorporation Date:
December 08, 2021
Key Executives
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Industria Farmaceutica Investpharma S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Total assets
19787.76%
Total equity
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?